Related Experiment Video

Updated: May 6, 2026

A Standardized Procedure of Dressing Management for Toxic Epidermal Necrolysis
07:22

A Standardized Procedure of Dressing Management for Toxic Epidermal Necrolysis

Published on: March 14, 2025

1.4K

Management of manifestations of epidermolysis bullosa

Ravindhra G Elluru1, Jose M Contreras, David M Albert

  • 1aCincinnati Children's Hospital, Cincinnati, Ohio, USA bClinica Alemana de Santiago, Santiago, Chile cGreat Ormond Street Hospital for Children, London, UK.

Current Opinion in Otolaryngology & Head and Neck Surgery
|October 26, 2013
PubMed

Insights

Epidermolysis bullosa (EB) management requires understanding its types and subtypes. Current care focuses on wound prevention and care, with future treatments exploring gene and protein replacement therapies.

Area of Science:

  • Otolaryngology
  • Genetics
  • Dermatology

Background:

  • Children with epidermolysis bullosa (EB) often experience ear, nose, and throat diseases linked to the condition's pathophysiology.
  • Effective management of otolaryngologic issues in EB necessitates a thorough understanding of EB diagnosis and its underlying mechanisms.

Purpose of the Study:

  • To review current nomenclature and diagnostic algorithms for epidermolysis bullosa.
  • To outline management strategies for cutaneous and mucosal lesions in EB patients.

Main Methods:

  • Utilizing immunofluorescent techniques for diagnosing EB based on characterized gene defects.
  • Reviewing guidelines developed by multidisciplinary groups through meta-analysis and expert panels.

Main Results:

  • Immunofluorescence is the primary diagnostic method for EB.
  • No definitive treatments currently exist for EB, but gene and protein replacement therapies show future promise.
  • Management strategies emphasize prevention and wound care for cutaneous and mucosal manifestations.

Conclusions:

  • Understanding EB subtypes, skin/mucosal involvement, and prognosis is crucial for individualized treatment plans.
  • Current EB management focuses on prevention and wound care principles.
  • Future therapeutic approaches may involve gene and protein replacement.
Abstract

More Related Videos

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis11:39

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

Published on: July 11, 2013

38.4K
Granulocyte-dependent Autoantibody-induced Skin Blistering12:23

Granulocyte-dependent Autoantibody-induced Skin Blistering

Published on: October 12, 2012

9.9K

Related Concept Videos

Burn Injuries01:22

Burn Injuries

Burn injuries occur when the skin and underlying tissues are damaged due to exposure to heat, electricity, chemicals, radiation, or friction. They can vary in severity, from minor superficial burns to severe deep burns that can be life-threatening.
The damage results in the death of skin cells, which can lead to a massive loss of fluid. Dehydration, electrolyte imbalance, and renal and circulatory failure follow, which can be fatal. Burn patients are treated with intravenous fluids to offset...
4.4K
Clinical Applications of Epidermal Stem Cells01:19

Clinical Applications of Epidermal Stem Cells

Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
2.4K
Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
5.2K
Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
821
Nephrotic Syndrome III : Nursing Management01:24

Nephrotic Syndrome III : Nursing Management

Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
561
Barrett Esophagus-II: Clinical Manifestations and Management01:21

Barrett Esophagus-II: Clinical Manifestations and Management

Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
1.8K